Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of ...

We determined the effect of breast irradiation plus tamoxifen on disease-free survival and local relapse in women 50 years of age or older who had T1 or T2 node-negative breast cancer. The rate of ...

Researchers appear to have found a solution for breast cancer patients who do not respond well enough to a common treatment.

MIDLOTHIAN, Va. (WWBT) - The Bon Secours Cancer Institute is participating in the Evangeline national clinical trial, which aims to find the best way to treat premenopausal women with breast cancer ...

Researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer and that it works against ...

Breast cancer patients who take the drug tamoxifen for 10 years instead of just the recommended five can further cut their chances of having the disease come back or kill them, researchers reported on ...

SAN ANTONIO — Daily use of low-dose (5 mg) tamoxifen (multiple brands) for a shorter-than-usual treatment period (3 years) for patients with ductal carcinoma in situ (DCIS) and other forms of ...

Postmenopausal women can use alternative drugs known as aromatase inhibitors, but those are not an option for younger ...

In a multicenter study, only 1 in 5 women at increased risk of breast cancer reported a strong need for tamoxifen preventive therapy, according to a report published Monday. In a multicenter study, ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...